Sorafenib remains standard therapy for advanced hepatocellular carcinoma

Sorafenib should remain standard therapy for patients with advanced hepatocellular carcinoma, following the negative results of the SEARCH clinical trial, researchers believe.

Liver cancer: standard treatment for hepatocellular carcinoma unchanged (photo: SPL)
Liver cancer: standard treatment for hepatocellular carcinoma unchanged (photo: SPL)

The SEARCH trial looked at 720 patients who were randomised 1:1 to receive either erlotinib and sorafenib or sorafenib plus placebo.

The primary endpoint of the phase III  randomised, double-blind, placebo-controlled trial was a 33% increase in the overall survival on the combination treatment in comparison to sorafenib/placebo.

Personalised medicines, access to cancer drugs and to palliative care are the main issues faced by oncology patients and their healthcare professionals in Europe and worldwide, according to the organisers of the 2012 meeting of the European Society of Medical Oncology.

According to a study from Oxford University annual healthcare costs per head of population for cancer range from 32 to 165 euros across EU countries.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Free coronavirus news and resources on GPonline, MIMS and MIMS Learning

Free coronavirus news and resources on GPonline, MIMS and MIMS Learning

As the coronavirus crisis continues, we at Haymarket are constantly seeking new ways...

Quarter of GPs self isolating for coronavirus as Hancock promises 100,000 tests a day

Quarter of GPs self isolating for coronavirus as Hancock promises 100,000 tests a day

Around one in four GPs are self isolating - many of them unnecessarily - as frontline...

Cashflow fears for locums as government relaxes 10-week pension rule

Cashflow fears for locums as government relaxes 10-week pension rule

Locums will have longer to declare pensionable income under plans to relax a 10-week...

More than 6,000 GPs in second wave of doctors given temporary GMC registration

More than 6,000 GPs in second wave of doctors given temporary GMC registration

More than 6,000 GPs who have retired or no longer hold a licence to practise are...

Updated PHE advice on PPE backs eye protection for GPs

Updated PHE advice on PPE backs eye protection for GPs

GPs should wear eye protection in addition to a mask, gloves and apron when providing...

Repurpose industry now to tackle PPE shortage, says doctors' union

Repurpose industry now to tackle PPE shortage, says doctors' union

UK industry should be 'immediately repurposed' to produce personal protective equipment...